NCT07197242 is a clinical trial in PCI, sponsored by Assiut University.

Who is sponsoring NCT07197242?

NCT07197242 is sponsored by Assiut University.

Is NCT07197242 still recruiting?

NCT07197242 is currently not yet recruiting. Last updated 29 September 2025.

Last reviewed 2025-09-29 · How we verify

NCT07197242

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prognostic Role of Lipoprotein(a) in Elective Percutaneous Coronary Revascularization

Not yet recruiting Last updated 29 September 2025

What this trial tests

trial in PCI in 156 participants. Not yet recruiting.

Timeline

1 October 2026

Primary endpoint
30 June 2027

30 December 2027

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	156
Start date	1 October 2026
Primary completion	30 June 2027
Estimated completion	30 December 2027

Conditions studied

PCI — all drugs for PCI →

Sponsor

Assiut University

Who can join

18 and older, any sex, with PCI. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study investigates the role of Lipoprotein(a) \[Lp(a)\] levels in predicting cardiovascular risk and adverse events in patients undergoing elective percutaneous coronary intervention (PCI).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for PCI

Currently open trials in the same condition.

NCT07297641 — Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR · recruiting
NCT07093788 — Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions · NA · recruiting
NCT07292909 — Effect of Empagliflozin on Inflammation · Phase 4 · recruiting
NCT06247982 — Bail-Out Stenting and Target-vessel Failure After Drug Coated Balloon Coronary percutaneouS Angioplasty for de Novo Lesi · active not recruiting
NCT03058627 — Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation · NA · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07197242 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 29 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07197242.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing